Integrated analysis of mRNA and microRNA expression profiles reveals differential transcriptome signature in ischaemic and dilated cardiomyopathy induced heart failure

References

• Sweet ME, Cocciolo A, Slavov D, et al. Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure. BMC Genomics. 2018;19(1):812.
   Google Scholar
• Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev. 1999;79(1):215–262.
   Google Scholar
• Beltrami CA, Finato N, Rocco M, et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation. 1994;89:151–163.
   Google Scholar
• Beltrami CA, Finato N, Rocco M, et al. The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol. 1995;27:291–305.
   Google Scholar
• Schirone L, Forte M, Palmerio S, et al. A review of the molecular mechanisms underlying the development and progression of cardiac remodeling. Oxid Med Cell Longev. 2017;2017:3920195.
   Google Scholar
• Delaunay M, Osman H, Kaiser S, et al. The role of cyclic AMP signaling in cardiac fibrosis. Cells. 2019;9(1):69.
   Google Scholar
• Malekar P, Hagenmueller M, Anyanwu A, et al. Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling. Hypertension. 2010;55(4):939–945.
   Google Scholar
• Khalil H, Kanisicak O, Prasad V, et al. Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis. J Clin Invest. 2017;127:3770–3783.
   Google Scholar
• Dobaczewski M, Chen W, Frangogiannis NG. Transforming growth factor (TGF)-β signaling in cardiac remodeling. J Mol Cell Cardiol. 2011;51:600–606.
   Google Scholar
• Zhang C-J, Huang Y, Lu J-D, et al. Upregulated microRNA-132 rescues cardiac fibrosis and restores cardiocyte proliferation in dilated cardiomyopathy through the phosphatase and tensin homolog-mediated PI3K/Akt signal transduction pathway. J Cell Biochem. 2018;120. DOI:10.1002/jcb.27081.
   Google Scholar
• Yang W, Wu Z, Yang K, et al. BMI1 promotes cardiac fibrosis in ischemia-induced heart failure via the PTEN-PI3K/Akt-mTOR signaling pathway. Am J Physiol Heart Circ Physiol. 2019;316(1):H61–H69.
   Google Scholar
• Huang Y. The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases. J Cell Mol Med. 2018;22(12):5768–5775.
   Google Scholar
• Kumarswamy R, Non-coding TT. RNAs in cardiac remodeling and heart failure. Circ Res. 2013;113:676–689.
   Google Scholar
• Vegter EL, van der Meer P, de Windt LJ, et al. MicroRNAs in heart failure: from biomarker to target for therapy. Eur J Heart Fail. 2016;18:457–468.
   Google Scholar
• Tijsen AJ, van der Made I, van den Hoogenhof MM, et al. The microRNA-15 family inhibits the TGFβ-pathway in the heart. Cardiovasc Res. 2014;104(1):61–71.
   Google Scholar
• Akat KM, Moore-McGriff DV, Morozov P, et al. Comparative RNA-sequencing analysis of myocardial and circulating small RNAs in human heart failure and their utility as biomarkers. Proc Natl Acad Sci USA. 2014;111(30):11151–11156.
   Google Scholar
• Grüning B, Dale R, Sjödin A, et al. Bioconda: sustainable and comprehensive software distribution for the life sciences. Nat Methods. 2018;15(7):475–476.
   Google Scholar
• Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37(1):1–13.
   Google Scholar
• Wulf-Johansson H, Lock Johansson S, Schlosser A, et al. Localization of microfibrillar-associated protein 4 (MFAP4) in human tissues: clinical evaluation of serum MFAP4 and its association with various cardiovascular conditions. PLoS ONE. 2013;8:e82243.
   Google Scholar
• Franco V, Chen Y-F, Oparil S, et al. Atrial natriuretic peptide dose-dependently inhibits pressure overload-induced cardiac remodeling. Hypertension. 2004;44(5):746–750.
   Google Scholar
• Tamura N, Ogawa Y, Chusho H, et al. Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci USA. 2000;97(8):4239–4244.
   Google Scholar
• Bai Y, Zhang P, Zhang X, et al. LTBP-2 acts as a novel marker in human heart failure - a preliminary study. Biomarkers. 2012;17:407–415.
   Google Scholar
• Engebretsen KVT, Lunde IG, Strand ME, et al. Lumican is increased in experimental and clinical heart failure, and its production by cardiac fibroblasts is induced by mechanical and proinflammatory stimuli. Febs J. 2013;280:2382–2398.
   Google Scholar
• Poveda J, Sanz AB, Fernandez-Fernandez B, et al. MXRA5 is a TGF-β1-regulated human protein with anti-inflammatory and anti-fibrotic properties. J Cell Mol Med. 2017;21(1):154–164.
   Google Scholar
• Tumelty KE, Smith BD, Nugent MA, et al. Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathways. J Biol Chem. 2014;289(5):2526–2536.
   Google Scholar
• Rocnik EF, Liu P, Sato K, et al. The novel SPARC family member SMOC-2 potentiates angiogenic growth factor activity. J Biol Chem. 2006;281(32):22855–22864.
   Google Scholar
• Bubenek S, Nastase A, Niculescu AM, et al. Assessment of gene expression profiles in peripheral occlusive arterial disease. Can J Cardiol. 2012;28(6):712–720.
   Google Scholar
• Barallobre-Barreiro J, Didangelos A, Schoendube FA, et al. Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury. Circulation. 2012;125(6):789–802.
   Google Scholar
• Zhu L, Vranckx R, Khau Van Kien P, et al. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet. 2006;38(3):343–349.
   Google Scholar
• van Nieuwenhoven FA, Munts C, Op’t Veld RC, et al. Cartilage intermediate layer protein 1 (CILP1): A novel mediator of cardiac extracellular matrix remodelling. Sci Rep. 2017;7(1):16042.
   Google Scholar
• Zhang C-L, Zhao Q, Liang H, et al. Cartilage intermediate layer protein-1 alleviates pressure overload-induced cardiac fibrosis via interfering TGF-β1 signaling. J Mol Cell Cardiol. 2018;116:135–144.
   Google Scholar
• Weng L-Q, Zhang W-B, Ye Y, et al. Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice. Acta Pharmacol Sin. 2014;35:1005–1014.
   Google Scholar
• Wang Q, Chen Y, Zhang D, et al. Activin receptor-like kinase 4 haplodeficiency mitigates arrhythmogenic atrial remodeling and vulnerability to atrial fibrillation in cardiac pathological hypertrophy. J Am Heart Assoc. 2018;7(16):e008842.
   Google Scholar
• Wu X-P, Wang H-J, Wang Y-L, et al. Serelaxin inhibits differentiation and fibrotic behaviors of cardiac fibroblasts by suppressing ALK-5/Smad2/3 signaling pathway. Exp Cell Res. 2018;362(1):17–27.
   Google Scholar
• Chen C, Ponnusamy M, Liu C, et al. MicroRNA as a therapeutic target in cardiac remodeling. Biomed Res Int. 2017;2017:1278436.
   Google Scholar
• Zhang X, Dong S, Jia Q, et al. The microRNA in ventricular remodeling: the miR-30 family. Biosci Rep. 2019;39. DOI:10.1042/BSR20190788.
   Google Scholar
• Li N, Zhou H, Tang Q. miR-133: A suppressor of cardiac remodeling? Front Pharmacol. 2018;9:903.
   Google Scholar
• Frangogiannis NG. The extracellular matrix in ischemic and nonischemic heart failure. Circ Res. 2019;125(1):117–146.
   Google Scholar
• Frangogiannis NG. The extracellular matrix in myocardial injury, repair, and remodeling. J Clin Invest. 2017;127(5):1600–1612.
   Google Scholar
• Zhang Y, Wei W, Shilova V, et al. Monoclonal antibody to marinobufagenin downregulates TGFβ profibrotic signaling in left ventricle and kidney and reduces tissue remodeling in salt-sensitive hypertension. J Am Heart Assoc. 2019;8:e012138.
   Google Scholar
• Guo Y, Gupte M, Umbarkar P, et al. Entanglement of GSK-3β, β-catenin and TGF-β1 signaling network to regulate myocardial fibrosis. J Mol Cell Cardiol. 2017;110:109–120.
   Google Scholar
• Ren D, Giri H, Li J, et al. The cardioprotective signaling activity of activated protein C in heart failure and ischemic heart diseases. Int J Mol Sci. 2019;20(7):1762.
   Google Scholar
• Andersen A, Povlsen JA, Johnsen J, et al. sGC-cGMP-PKG pathway stimulation protects the healthy but not the failing right ventricle of rats against ischemia and reperfusion injury. Int J Cardiol. 2016;223:674–680.
   Google Scholar
• Wang Y, Li ZC, Zhang P, et al. Nitric oxide-cGMP-PKG pathway acts on orai1 to inhibit the hypertrophy of human embryonic stem cell-derived cardiomyocytes. Stem Cells. 2015;33(10):2973–2984.
   Google Scholar
• Ji F, Wang K, Zhang Y, et al. MiR-542-3p controls hepatic stellate cell activation and fibrosis via targeting BMP-7. J Cell Biochem. 2019;120(3):4573–4581.
   Google Scholar
• Wu Y, You J, Li F, et al. MicroRNA-542-3p suppresses tumor cell proliferation via targeting Smad2 inhuman osteosarcoma. Oncol Lett. 2018;15:6895–6902.
   Google Scholar
• Yan D, Zhao -L-L, Yue B-W, et al. Granule of BU-XIN RUAN-MAI attenuates the patients’ angina pectoris of coronary heart disease via regulating miR-542-3p/GABARAP Signaling. Evid Based Complement Alternat Med. 2019;2019:1808419.
   Google Scholar
• Zhao Y, Li Y, Tong L, et al. Analysis of microRNA expression profiles induced by yiqifumai injection in rats with chronic heart failure. Front Physiol. 2018;9:48.
   Google Scholar